{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:25:54Z","timestamp":1789691154010,"version":"4.0.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Indian Journal of Medical Microbiology"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.ijmmb.2023.01.011","type":"journal-article","created":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T13:59:31Z","timestamp":1683899971000},"page":"100353","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Invasive fungal infections in hemato-oncology"],"prefix":"10.1016","volume":"44","author":[{"given":"Jaswinder Kaur","family":"Oberoi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lata","family":"Sheoran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanu","family":"Sagar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonal","family":"Saxena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijmmb.2023.01.011_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2014.12.021","article-title":"Invasive infections due to filamentous fungi other than Aspergillus: epidemiology and determinants of mortality","volume":"21","author":"Slavin","year":"2015","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"10.1016\/j.ijmmb.2023.01.011_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-019-3901-y","article-title":"A\u00a0population-based analysis of invasive fungal disease in haematology-oncology patients using data linkage of state-wide registries and administrative databases: 2005-2016","volume":"19","author":"Valentine","year":"2019","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijmmb.2023.01.011_bib3","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3324\/haematol.2010.030825","article-title":"Impact of invasive fungal disease on the chemotherapy schedule and event-free survival in acute leukemia patients who survived fungal disease: a case-control study","volume":"96","author":"Even","year":"2011","journal-title":"Haematol"},{"issue":"5","key":"10.1016\/j.ijmmb.2023.01.011_bib4","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/(SICI)1096-911X(199905)32:5<344::AID-MPO6>3.0.CO;2-6","article-title":"Fungal colonization and infection in children with acute leukemia and lymphoma during induction therapy","volume":"32","author":"G\u00f6zda\u015fo\u011dlu","year":"1999","journal-title":"Med Pediatr Oncol"},{"issue":"5","key":"10.1016\/j.ijmmb.2023.01.011_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0216715","article-title":"Epidemiology and treatment approaches in management of invasive fungal infections in hematological malignancies: results from a single-centre study","volume":"14","author":"Fracchiolla","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.ijmmb.2023.01.011_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ofid\/ofw268","article-title":"Trends in hospitlizations related to invasive aspergillosis and mucormycosis in the United States, 2000 - 2013","volume":"4","author":"Vallabhaneni","year":"2017","journal-title":"Open Forum Infect Dis"},{"issue":"5","key":"10.1016\/j.ijmmb.2023.01.011_bib7","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/cid\/ciy181","article-title":"Epidemiology and outcomes of hospitalizations with invasive aspergillosis in the United States, 2009-2013","volume":"67","author":"Zilberberg","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijmmb.2023.01.011_bib8","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/myc.12646","article-title":"Invasive fungal infection following chemotherapy for acute myeloid leukaemia\u2014experience from a developing country","volume":"60","author":"Korula","year":"2017","journal-title":"Mycoses"},{"key":"10.1016\/j.ijmmb.2023.01.011_bib9","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1007\/s12288-017-0894-9","article-title":"Invasive fungal infections in acute promyelocytic leukemia on dual differentiating agents: real world data","volume":"34","author":"Yanamandra","year":"2018","journal-title":"Indian J Hematol Blood Transfus"},{"key":"10.1016\/j.ijmmb.2023.01.011_bib10","series-title":"Clinical practice of medical mycology in Asia","year":"2020"},{"issue":"6","key":"10.1016\/j.ijmmb.2023.01.011_bib11","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European Organization for research and treatment of cancer and the mycoses study Group Education and research Consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.ijmmb.2023.01.011_bib12","first-page":"711","article-title":"Non\u2013culture-based diagnostics for opportunistic fungi","volume":"20","author":"Mennink-Kersten","year":"2006","journal-title":"Infect Dis Clinic"},{"issue":"3","key":"10.1016\/j.ijmmb.2023.01.011_bib13","doi-asserted-by":"crossref","first-page":"322-7","DOI":"10.1016\/j.diagmicrobio.2014.03.020","article-title":"Clinical utility of Aspergillus galactomannan and PCR in bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in patients with haematological malignancies","volume":"79","author":"Heng","year":"2014","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijmmb.2023.01.011_bib14","doi-asserted-by":"crossref","first-page":"661","DOI":"10.3389\/fmicb.2018.00661","article-title":"Galactomannan, a surrogatemarker for outcome in invasive aspergillosis: finally coming of age","volume":"9","author":"Mercier","year":"2018","journal-title":"Front Microbiol"},{"issue":"12","key":"10.1016\/j.ijmmb.2023.01.011_bib15","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.cmi.2017.05.006","article-title":"The misleading effect of serum galactomannan testing in high-risk haematology patients receiving prophylaxis with micafungin","volume":"23","author":"Vena","year":"2017","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"10.1016\/j.ijmmb.2023.01.011_bib16","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1469-0691.2011.03589.x","article-title":"Pre-emptive diagnosis and treatment of fungal infections\u2013evaluation of a single-centre policy","volume":"18","author":"Schneider","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijmmb.2023.01.011_bib17","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1128\/JCM.42.6.2733-2741.2004","article-title":"Prospective comparison of the diagnostic potential of real-time PCR, double-sandwich enzyme-linked immunosorbent assay for galactomannan, and a (1,3)-beta-D-glucan test in weekly screening for invasive aspergillosis in patients with hematological disorders","volume":"42","author":"Kawazu","year":"2004","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.ijmmb.2023.01.011_bib18","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1086\/432470","article-title":"Multicenter clinical evaluation of the (1,3) beta-Dglucan assay as an aid to diagnosis of fungal infections in humans","volume":"41","author":"Saeki","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijmmb.2023.01.011_bib19","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1365-2141.2004.04904.x","volume":"125","author":"Buchheidt","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ijmmb.2023.01.011_bib20","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s10096-008-0616-1","article-title":"Diagnosis of invasive aspergillosis using bronchoalveolar lavage in haematology patients: influence of bronchoalveolar lavage human DNA content on real-time PCR performance","volume":"28","author":"Frealle","year":"2009","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"9","key":"10.1016\/j.ijmmb.2023.01.011_bib21","article-title":"Polymerase chain reaction blood tests for the diagnosis of invasive aspergillosis in immunocompromised people","author":"Cruciani","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.ijmmb.2023.01.011_bib22","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01867-18","article-title":"Evaluation of mass spectrometry-based detection of Panfungal serum disaccharide for diagnosis of invasive fungal infections: results from a Collaborative study involving Six European clinical centers","volume":"57","author":"Cornu","year":"2019","journal-title":"J\u00a0Clin Microbiol"},{"issue":"5","key":"10.1016\/j.ijmmb.2023.01.011_bib23","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1128\/JCM.02838-12","article-title":"Electronic nose technology for detection of invasive pulmonary aspergillosis in prolonged chemotherapy-induced neutropenia: a proof-of-principle study","volume":"51","author":"de Heer","year":"2013","journal-title":"J\u00a0Clin Microbiol"},{"issue":"3","key":"10.1016\/j.ijmmb.2023.01.011_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151260","article-title":"Detection of a serum siderophore by LC-MS\/MS as a potential biomarker of invasive aspergillosis","volume":"11","author":"Carroll","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ijmmb.2023.01.011_bib25","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1099\/jmm.0.006452-0","article-title":"Prospective evaluation of mannan and anti-mannan antibodies for diagnosis of invasive Candida infections in patients with neutropenic fever","volume":"58","author":"Ellis","year":"2009","journal-title":"J\u00a0Med Microbiol"},{"issue":"Suppl 2","key":"10.1016\/j.ijmmb.2023.01.011_bib26","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1439-0507.2008.01572.x","article-title":"Antifungal treatment strategies in high risk patients","volume":"51","author":"R\u00fcping","year":"2008","journal-title":"Mycoses"},{"issue":"1","key":"10.1016\/j.ijmmb.2023.01.011_bib27","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1439-0507.2010.01961.x","article-title":"Antifungal treatment strategies in patients with haematological diseases or cancer: from prophylaxis to empirical, pre-emptive and targeted therapy","volume":"55","author":"Mikolajewska","year":"2012","journal-title":"Mycoses"},{"issue":"7","key":"10.1016\/j.ijmmb.2023.01.011_bib28","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/myc.13082","article-title":"Treatment of invasive fungal diseases in cancer patients\u2014revised 2019 recommendations of the infectious diseases Working party (AGIHO) of the German society of Hematology and oncology (DGHO)","volume":"63","author":"Ruhnke","year":"2020","journal-title":"Mycoses"},{"key":"10.1016\/j.ijmmb.2023.01.011_bib29","first-page":"3221","article-title":"European guidelines for primary antifungal prophylaxis in adult haematology patients: summary of the updated recommendations from the European Conference on Infections in Leukaemia","volume":"73","year":"2018","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"2","key":"10.1016\/j.ijmmb.2023.01.011_bib30","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1469-0691.2011.03589.x","article-title":"Pre-emptive diagnosis and treatment of fungal infections\u2013evaluation of a single-centre policy","volume":"18","author":"Schneider","year":"2012","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"10.1016\/j.ijmmb.2023.01.011_bib31","doi-asserted-by":"crossref","first-page":"464","DOI":"10.3324\/haematol.2011.049999","article-title":"Universal antifungal therapy is not needed in persistent febrile neutropenia: a tailored diagnostic and therapeutic approach","volume":"97","author":"Aguilar-Guisado","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/j.ijmmb.2023.01.011_bib32","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S1473-3099(17)30316-X","article-title":"The global problem of antifungal resistance: prevalence, mechanisms, and management","volume":"17","author":"Perlin","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijmmb.2023.01.011_bib33","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ijantimicag.2017.05.019","article-title":"Epidemiology of antifungal resistance in human pathogenic yeasts: current viewpoint and practical recommendations for management","volume":"50","author":"Farmakiotis","year":"2017","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijmmb.2023.01.011_bib34","doi-asserted-by":"crossref","first-page":"4116","DOI":"10.1128\/AAC.00896-10","article-title":"Pharmacokinetics, safety, and tolerability of voriconazole in hospitalized immunocompromised children","volume":"54","author":"Walsh","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijmmb.2023.01.011_bib35","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S1473-3099(09)70265-8","article-title":"Azole resistance in Aspergillus fumigatus: a side-effect of environmental fungicide use?","volume":"9","author":"Verweij","year":"2009","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijmmb.2023.01.011_bib36","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1093\/cid\/ciw691","article-title":"Simultaneous emergence of multidrug-resistant Candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses","volume":"64","author":"Lockhart","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijmmb.2023.01.011_bib37","first-page":"237","article-title":"Breakthrough invasive fungal diseases during voriconazole treatment for aspergillosis: a 5-year retrospective cohort study","volume":"55","author":"Kim","year":"2017","journal-title":"Med Mycol"},{"key":"10.1016\/j.ijmmb.2023.01.011_bib38","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1007\/s12185-009-0296-3","article-title":"Monitoring trough concentration of voriconazole is important to ensure successful antifungal therapy and to avoid hepatic damage in patients with hematological disorders","volume":"89","author":"Ueda","year":"2009","journal-title":"Int J Hematol"},{"key":"10.1016\/j.ijmmb.2023.01.011_bib39","doi-asserted-by":"crossref","first-page":"996","DOI":"10.3324\/haematol.2009.012633","article-title":"Prophylaxis of invasive aspergillosis with voriconazole or caspofungin during building work in patients with acute leukemia","volume":"95","author":"Chabrol","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.ijmmb.2023.01.011_bib40","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ajic.2011.03.031","article-title":"Hospital environment and invasive aspergillosis in patients with hematologic malignancy","volume":"40","author":"Lee","year":"2012","journal-title":"Am J Infect Control"}],"container-title":["Indian Journal of Medical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0255085723000117?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0255085723000117?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T19:20:54Z","timestamp":1759346454000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0255085723000117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":40,"alternative-id":["S0255085723000117"],"URL":"https:\/\/doi.org\/10.1016\/j.ijmmb.2023.01.011","relation":{},"ISSN":["0255-0857"],"issn-type":[{"value":"0255-0857","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Invasive fungal infections in hemato-oncology","name":"articletitle","label":"Article Title"},{"value":"Indian Journal of Medical Microbiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijmmb.2023.01.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Indian Association of Medical Microbiologists. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100353"}}